During a panel discussion at HLTH, Chelsea Clinton shared three things she wants healthcare leaders to know going into the election when it comes to reproductive health.
Join us tomorrow for an insightful discussion aimed at delving into how employers are tackling the intricate challenges posed by rising healthcare costs while prioritizing employee health and well-being. This c-suite discussion includes the perspectives and sometimes competing vantage points of the CFO, CHRO, and CMO.
Join us Thursday, October 24, at 1pm ET for a webinar sponsored by Personify Health on how employers navigate the intricate challenges posed by rising healthcare costs while prioritizing employee health and well-being.
Editas Medicine says its ex vivo gene-editing therapy for hemoglobinopathies has best-in-class potential, but the company plans to out-license or partner that program. Editas is shifting focusing to in vivo gene-editing therapies.
Both providers and payers face challenges and understanding the requirements and needs of each stakeholder has the potential to lower the temperature of the current rhetoric.
Highly preventable if diagnosed and managed early, CAD should be a healthcare priority. Both patients and providers have pivotal roles in driving this change.
In this episode, we talk about virtual care and how Dr. Eve Cunningham approaches technology to scale remote care programs to help physicians managing chronic disease patients. We also address how the Federal Trade Commission is suing the three largest pharmacy benefit managers for their role in keeping insulin prices high when lower priced insulin was already available.
No comments